
Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
WSFX Global Pay Q1 FY27: Revenue ₹1,491 Cr, PAT ₹0.30 Cr | Arthneeti
Q1 FY27
Gross Turnover (Q1 FY27): ₹1,491 Crore, up 36.24% YoY (Page 2, 6, 9) . Key investor presentation takeaways from WSFX Global Pay Ltd's Q1 FY27 investor presentation — and how it…
18 Oct 2026
Devson Catalyst Q1 FY27 investor presentation: Revenue & Margins | Arthneeti
Q1 FY27
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector peers.
18 Oct 2026
Brahmaputra Infrastructure Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Current order book as of March 2026: INR 1,600 crores, equivalent to 4.46x FY26 revenue. Key concall takeaways from Brahmaputra Infrastructure Ltd's Q4 FY26…
18 Oct 2026
Brahmaputra Infrastructure Q1 FY27: Revenue ₹110.79 Cr | Arthneeti
Q1 FY27
Strong revenue growth:** Consolidated top line grew 20% YoY to ₹110.79 crore in Q1 FY27, marking the first ₹100+ crore quarter in 10 years. Key concall…
18 Oct 2026
Regency Fincorp Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Disbursements grew 43% YoY to INR 142 crores in FY2026. Key concall takeaways from Regency Fincorp's Q4 FY26 earnings call — and how it ranks against sector…
18 Oct 2026
Regency Fincorp Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
. Key concall takeaways from Regency Fincorp's Q1 FY27 earnings call — and how it ranks against sector peers.
18 Oct 2026
Rossari Biotech Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
H1 revenue grew 20% YoY, driven largely by volume growth rather than price increases (Page 9). Key concall takeaways from Rossari Biotech's Q2 FY27 earnings…
18 Oct 2026
Hero Motors Q2 FY27 investor presentation: Revenue & Margins | Arthneeti
Q2 FY27
Consolidated Revenue from Operations Q1-FY27:** ₹3,193 Mn, up 24.9% YoY from ₹2,557 Mn in Q1-FY26 . Key investor presentation takeaways from Hero Motors Ltd's Q2 FY27…
17 Oct 2026
Lagnam Spintex Q2 FY27 results statement: Revenue & Margins | Arthneeti
Q2 FY27
13,242.61 Lacs (approximate increase of 30.3%) . Key results statement takeaways from Lagnam Spintex's Q2 FY27 results statement — and how it ranks against sector peers.
17 Oct 2026
Bajaj Healthcare Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
FY27 Capex planned between INR 65 crores to INR 80 crores. Key concall takeaways from Bajaj Healthcare Ltd's Q2 FY27 earnings call — and how it ranks against…
17 Oct 2026
Parin Enterprises Q2 FY27 results statement: Revenue & Margins | Arthneeti
Q2 FY27
For the quarter ended 30 September 2026, consolidated revenue from operations was ₹8,643.27 lakhs. Key results statement takeaways from Parin Enterprises Ltd's Q2 FY27…
17 Oct 2026
Delaplex Q1 FY27 investor presentation: Revenue & Margins | Arthneeti
Q1 FY27
H2 FY26 total income (quarterly equivalent): ₹340.4 Mn vs ₹328.4 Mn in H2 FY25, a 3.66% YoY increase. Key investor presentation takeaways from Delaplex Ltd's Q1 FY27…
17 Oct 2026
IDBI Bank Q2 FY27 results statement: Revenue & Margins | Arthneeti
Q2 FY27
8,512.14 crore (up from Rs. Key results statement takeaways from IDBI Bank Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
17 Oct 2026
Rishi Laser Q1 FY27: Revenue ₹42.26 Cr, PAT ₹0.50 Cr | Arthneeti
Q1 FY27
Q1 FY27 Revenue: ₹42.26 Cr, up 2.99% YoY (from ₹41.03 Cr in Q1 FY26). Key investor presentation takeaways from Rishi Laser Ltd's Q1 FY27 investor presentation — and how it ranks…
17 Oct 2026
Apollo Finvest (India) Q1 FY27: Revenue ₹25.9 Cr, PAT ₹11.34 Cr | Arthneeti
Q1 FY27
The presentation reports **total income of ₹25.9 crore for Q1 FY27**, up from ₹21.6 crore in Q1 FY26, indicating a **year-on-year growth of 20%**. Key investor presentation…
17 Oct 2026
Himalaya Nutravedics India Q2 FY27 investor presentation: Revenue & Margins | Arthneeti
Q2 FY27
Reported revenue from operations for FY26: ₹4,306.8 lakhs, a year-on-year increase of 105.1% from ₹2,099.7 lakhs in FY25 (Page 22, 14, 5, 4). Key investor presentation…
17 Oct 2026
Yes Bank Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
With a pro forma CET-1 ratio of 11.4%, the bank believes growth ambitions are not compromised and can grow at approximately 11% without capital dilution…
17 Oct 2026
Punjab & Sind Bank Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Net interest income has grown by 22%, indicating improving margins. Key concall takeaways from Punjab & Sind Bank's Q2 FY27 earnings call — and how it ranks…
17 Oct 2026
Kross Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Capex of INR170 crores planned for seamless tube and expansion, supporting future capacity and volume growth. Key concall takeaways from Kross Ltd's Q2 FY27…
17 Oct 2026
India Cements Q2 FY27 earnings call: Revenue & Margins | Arthneeti
Q2 FY27
Capital allocation includes INR1,800 crores capex for Ultravolt; ramp-up continues. Key concall takeaways from India Cements Ltd's Q2 FY27 earnings call — and…
17 Oct 2026
Arthneeti Pro · Annual
Every earnings call this season,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access